PI
RLAY icon

Putnam Investments’s Relay Therapeutics RLAY Stock Holding History

Putnam Investments’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60,418
Closed -$1.35M – 1182
2022
Q3 		$1.35M Sell
60,418
-1,098
-2% -$24.1K ﹤0.01% 807
2022
Q2 		$1.03M Sell
61,516
-762
-1% -$16.3K ﹤0.01% 852
2022
Q1 		$1.86M Sell
62,278
-4,717
-7% -$114K ﹤0.01% 814
2021
Q4 		$2.06M Buy
+66,995
New +$2.12M ﹤0.01% 760

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Putnam Investments's RLAY Position: Q4 2022 in Review

Putnam Investments sold out of Relay Therapeutics (RLAY) in Q4 2022, closing a stake of 60,418 shares — an estimated $1.35M sold.

Putnam Investments first reported a position in RLAY in Q4 2021 and held it in 4 quarters. The position peaked at $2.06M in Q4 2021. 165 funds tracked by Wall St. Rank hold RLAY as of Q4 2022.

  • Putnam Investments reported no remaining Relay Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Putnam Investments sold 60,418 Relay Therapeutics shares in Q4 2022, an estimated $1.35M.
  • Putnam Investments first reported a position in Relay Therapeutics in Q4 2021 and held it in 4 quarters.
  • Putnam Investments's Relay Therapeutics position peaked at $2.06M in Q4 2021.
  • 165 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2022.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.